Report updated Jun 6, 2026
Biotech News Today: Industry & Research Updates
For biotechnology professionals, researchers, and investors interested in industry trends and corporate news.
Biotech News Today: Industry & Research Updates is an established news app that is free with in-app purchases. With a 4.6/5 rating from 53 reviews, it shows polarized user reception.
What is Biotech News Today: Industry & Research Updates?
Biotech News Today is a news aggregation app for biotechnology professionals and investors, providing industry updates and corporate market tracking on iOS.
Users hire this app to monitor niche research fields and corporate stock news in one place, reducing the time spent manually scanning multiple industry sources.
Current Momentum
v1.0
- No feature updates since 2017.
- Maintenance-mode status limits growth.
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Provides updates on research fields including immunotherapy, bioinformatics, and genetic engineering.
Delivers dedicated news coverage for top biotech companies such as Johnson & Johnson, Roche, and Pfizer.
Includes a library of educational and informative biotechnology videos.
Offers push notifications to ensure users receive important news headlines in real-time.
How much does it cost?
- Free
- Pro (In-app purchase)
Freemium model gates ad-removal and expanded corporate news coverage behind a one-time Pro upgrade.
Who Built It?
Juicestand
Providing localized news, radio, and niche interest content to global audiences. Juicestand Inc aggregates digital media to keep users informed.
Portfolio
13
Apps
What other apps does Juicestand make?
Pakistan News Express Daily - Today's Latest
Kenya News Today- Latest Nairobi & Mombasa Updates
Immigration News & Latest Refugee Updates Free
News Australia - Latest Australian Headlines
Canada News Today - Latest Breaking Headlines
HK News: Hong Kong Today & Radio Free Edition
Explore the full Juicestand report
Portfolio breakdown, audience, momentum, and every app published by Juicestand.
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Biotech News Today: Industry & Research Updates?
How's The News Market?
How does it evolve in the News market?
Biotech News Today ranks #88 Free in its category, reflecting its status as a niche utility. The lack of updates since 2017 suggests a stagnant position that limits growth against more active competitors.
Rank progression
5 active rankings tracked, 30-day window
The rivals identified
Same space(1)
Both apps function as specialized industry news aggregators that serve professional audiences requiring high-frequency updates on niche market sectors.
Differentiators
- Integrates multimedia podcast content directly into the news feed for a more engaging user experience.
- Provides exclusive access to virtual industry events, creating a community-driven value proposition beyond simple news.
- Maintains a more active development cycle with recent updates, ensuring better compatibility with modern iOS versions.
Compare Biotech News Today: Industry & Research Updates against every rival
All rivals in one side-by-side table: identity, store metrics, ratings & sentiment, and strategic intel, plus a head-to-head page for each.
The outtake for Biotech News Today: Industry & Research Updates
Strengths to defend, gaps to attack
Core Strengths
- Corporate news tracking for top-tier entities provides clear utility for industry professionals.
- Notification-driven retention loop ensures users remain informed of market-moving headlines.
Critical Frictions
- Stagnant development cycle with no updates since 2017 creates compatibility risks.
- Lack of original content or community features limits user engagement.
Growth Levers
- Integration of virtual industry events could shift the app to a community hub.
- Expansion of the corporate tracking list could increase Pro subscription value.
Market Threats
- Active competitors like FreightWaves News capture market share via multimedia content.
- OS-level compatibility issues from lack of updates erode user trust.
What are the next best moves?
Audit codebase for iOS compatibility because the app has not been updated since 2017 → prevent total churn.
The 2017 release date indicates a high risk of failure on current iOS versions.
Trade-off: Pause all new feature development — stability is the immediate survival priority.
Pivot to a community-driven model because competitors like FreightWaves News are gaining share → increase retention.
Competitor analysis shows multimedia and community features are the current industry standard.
Trade-off: Deprioritize the expansion of the corporate news list — community features have higher retention impact.
A counter-intuitive read
The app's lack of updates is not just a technical failure but a strategic vulnerability, as it signals to professional users that the platform is no longer a reliable source for time-sensitive market data.
Feature Gaps vs Competitors
- Multimedia podcast integration (available in FreightWaves News but absent here)
- Virtual industry event access (available in FreightWaves News but absent here)
Key Takeaways
Biotech News Today provides a functional news feed for professionals but risks obsolescence due to a lack of updates since 2017, so the PM must prioritize basic iOS compatibility to prevent total user loss.
Where Is It Heading?
Declining
The market for industry news is shifting toward community-driven, multimedia-rich platforms that offer more than just text aggregation. Biotech News Today is currently exposed to churn because it lacks the engagement loops necessary to compete, so the PM must decide whether to invest in a major feature overhaul or sunset the product.
The lack of updates since 2017 indicates the app is in maintenance mode, which prevents it from competing with active industry news aggregators.
Competitors like FreightWaves News are integrating community features, which will likely drain the subject app's professional user base over the coming quarters.